glp 1 agonist drug GLP-1 receptor agonists GLP-1 Receptor Agonists as Treatments
Description
Both are sold by Danish drug giant Novo Nordisk
BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice
Int J Surg
Yet it is Lillys newest drug, tirzepatide, which poses a more serious threat to Novos market dominance
doi: 10.5902/2179460X25443
After weekly subcutaneous injection, EX was slowly released from the microspheres by diffusion and microsphere rupture and reached a stable plasma concentration about 6-8 weeks after treatment (114)
